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Zusammenfassung
In-beam Positronen Emissions Tomographie (in-beam PET) ist zur Zeit die einzige Methode für
eine in-situ Kontrolle der Ionentherapie mit geladenen Hadronen. Bei solch einer Therapie wer-
den die klinischen Auswirkungen einer Abweichung von der Bestrahlungsplanung durch Sicher-
heitssäume um den Tumor und geeignete Einstrahlrichtungen kompensiert. Darüber hinaus
erlaubt die in-beam PET Methode Reichweiteabweichungen und anatomische Veränderungen
während der fraktionierten Bestrahlung nachzuweisen. Mittels in-beam PET detektierter Ab-
weichungen ist es möglich, die Diﬀerenz zwischen geplanter und applizierter Dosis abzuschätzen.
Erstmals in der klinischen Strahlentherapie wurde in-beam PET vom Forschungszentrum
Rossendorf (FZR), Dresden an der Gesellschaft für Schwerionenforschung (GSI) in Darmstadt
implementiert. Der eingebaute Tomograph ist für kleine Tumoren optimiert und besteht aus
zwei sphärischen Detektorköpfen. Dadurch treten im Falle großer Bestrahlungsfelder un-
korrigierbare Artefakte auf, welche die Bildauswertung stören. In dieser Arbeit zeigt eine
Simulation, die mit einem 3D-Rekonstruktionsprogramm gekoppelt ist, dass die Verminderung
des Öﬀnungswinkels einer zylinderförmigen Doppelkopf Kamera der ausschlaggebende Fak-
tor ist, um eine optimale Qualität der in-beam PET-Bilder zu erhalten. Das Ergebnis der
Studie sind zwei bevorzugte Detektoranordnungen: ein geschlossener Ring oder ein Doppelkopf
Tomograph mit kleinen, einander gegenüber liegenden Öﬀnungen für den Eintritt des Therapie-
strahls und den Austritt leichter Targetfragmente. Die Integration beider Detektoranordnungen
in eine isozentrisch rotierende Ionenstrahlführung (Gantry) ist durchführbar, wenn der in-
beam PET-Scanner an die Ionenstrahlführung gekoppelt wird. Es ist auch möglich, einen
in-beam PET-Scanner mit den erwähnten Detektoranordnungen an therapeutischen Anla-
gen mit einer horizontalen Strahlführung zu implementieren. Die vorgeschlagenen Detektor-
konﬁgurationen waren hinsichtlich ihrer Bild gebenden Eigenschaften am Teilchstrahl zu unter-
suchen - dies ist eine Schlussfolgerung auf die an der Schwerionentherapie-Anlage des Lawrence
Berkeley Laboratory eingetretene Situation. Dort konnte in-beam PET nicht in die klini-
sche Nutzung überführt werden, weil es, höchstwahrscheinlich bedingt durch den mit der
passiven Formierung des Bestrahlungsfeldes einhergehenden Fluss an Sekundärteilchen, zu
einer Aktivierung der Szintillations-Detektoren aus Bismut-Germanat kam. Die Untergrund-
ereignisse aus dieser Kristall-Aktivierung verhinderten das Registrieren von in-beam PET
Daten mit einem für die Bildgebung ausreichenden Signal-Rausch-Verhähltnis. Deswegen
mussten Detektoren basierend auf dem in den 1990er Jahren gefunden Szintillator LSO (Lute-
tiumoxyorthosilikat), der bereits verbreiteten Eingang in die PET Tracer Bildgebung gefunden
hat, auf ihre Eignung für die Bildgebung am Teilchenstrahl untersucht werden. Jeder Detektor
besteht aus 32 LSO-Kristallen, welche mit einer Lawinen-Photodioden-Matrix (avalanche pho-
todiode array, APDA) optisch gekoppelt sind. Wegen ihrer Kompaktheit und ihrer Unempﬁnd-
lichkeit gegenüber Magnetfeldern wurden die APDA anstelle von Photomultipliern (photo-
multiplier tube, PMT) als Szintillations-Detektoren gewählt. Ein magnetisch unempﬁndlicher
Detektor ist notwendig, wenn der in-beam PET-Scanner nahe dem letzten Magneten der Strahl-
führung montiert ist. Dies gilt besonders für die geplante isozentrisch rotierende Ionenstrahl-
führung an der Heidelberger Ionen-Therapie-Anlage, die sich bereits in der Bauphase beﬁndet.
Um beide Dektektoren im Koinzidenzmodus sowohl oine, als auch synchronisiert mit der
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medizinischen Strahlführung der GSI auslesen zu können, wurde ein Mehrkanal-Listmode-
Datenerfassungssystem aufgebaut. Eine Mess-Position, bei der der Winkel zwischen den zwei
LSO/APDA Detektoren und dem Isozentrum sehr klein war, zeigte gute Ergebnisse für die
in-beam PET-Bildgebung. Solche Kleinwinkel-Messungen sind durchgeführt worden, wobei
beide Detektoren in Strahlrichtung vor oder hinter dem Target positioniert waren. Dabei hat
sich gezeigt, dass die Detektoren eine gute Lösung für die in dieser Arbeit vorgeschlagenen,
verbesserten in-beam PET-Scanner sind. Eine weitere Bestätigung dieses Ergebnisses folgt aus
γ-Spektren, die mit einem Germanium-Detektor aufgenommen wurden. Nach dem Einsatz des
Szintillators bei Patientenbestrahlungen war keine Aktivierung des LSO-Szintillators nachweis-
bar.
Obwohl ein geschlossener Ring oder ein Doppelkopf Tomograph mit kleinen Öﬀnungen ver-
besserte in-beam PET-Bilder ermöglichen, stellt die niedrige Zählrate beim in-beam PET ein
zweites Problem bezüglich der Bildqualität dar. Es wird durch einen erhöhten Untergrund an
zufälligen Koinzidenzereignissen während der Strahlextraktion hervorgerufen. Noch wichtiger
ist, dass neue Beschleunigerentwicklungen dieses Problem weiter erhöhen werden, bis zu einem
Grad, bei dem in-beam PET-Datenaufnahme unmöglich wird, wenn das bisher angewandte
Prinzip der Datenerfassung weiter benutzt wird. Es sind zwei Methoden zur Unterdrückung
solcher Zufallsereignisse geprüft worden. Beide haben die Synchronisation der detektierten
Ereignisse mit der vom Beschleuniger vorgegeben Zeit-Mikrostruktur des Teilchenstrahles zur
Grundlage. Eine Methode erreicht diese Synchronisierung durch einen schnellen Teilchen-
detektor, der vor dem Isozentrum im Strahlweg positioniert ist. Dies ermöglicht, Photonen-
koinzidenzen, die während der Extraktion der Ionenpakete detektiert werden, für die Bild-
rekonstruktion zu verwerfen. Eine zweite Methode besteht in der Synchronisation jeder
Photonenkoinzidenz mit dem Hochfrequenz-Signal des Beschleunigers. Die Bildstatistik wurde
durch diesen Methoden fast um den Faktor zwei verbessert. Dies zeigt, dass die Methoden
und deren Datenerfassungstechnik eine Lösung für zukünftige in-beam Positronen Emissions
Tomographen darstellen, unabhängig davon, ob es sich bei dem Therapiebeschleuniger um ein
Synchrotron oder Zyklotron handelt.
Overview
Summary
In-beam positron emission tomography (in-beam PET) is currently the only method for an
in-situ monitoring of highly tumor-conformed charged hadron therapy. In such therapy, the
clinical eﬀect of deviations from treatment planning is highly minimized by implementing safety
margins around the tumor and selecting proper beam portals. Nevertheless, in-beam PET is
able to detect eventual, undesirable range deviations and anatomical modiﬁcations during
fractionated irradiation, to verify the accuracy of the beam portal delivered and to provide the
radiotherapist with an estimation of the diﬀerence in dosage if the treatment delivered diﬀers
from the planned one.
With unprecedented success in clinical radiotherapy, the in-beam PET implemented by the
team from the Forschungszentrum Rossendorf (FZR), Dresden, at the Gesellschaft für Schwer-
ionenforschung (GSI), Darmstadt, was optimized for the initially expected, small-sized tumors.
For large irradiation ﬁelds, though, uncorrectable limited-angle reconstruction artifacts arise
due to the dual-head, spherical camera geometry, disturbing image evaluation in such cases. In
a ﬁrst study within this work, a set of simulation and fully-3D reconstruction routines shows
that minimizing the opening angle of a cylindrical camera is determinant for an optimum quality
of the in-beam PET images. The study yields two favorite detector geometries: a closed ring
or a dual-head tomograph with narrow gaps. The implementation of either detector geometry
onto an isocentric, ion beam delivery (gantry) is feasible by mounting the PET scanner at the
beam nozzle. The implementation of an in-beam PET scanner with the mentioned detector
geometries at therapeutic sites with a ﬁxed, horizontal beam line is also feasible. Nevertheless,
knowing that previous in-beam PET research in Berkeley was abandoned due to detector
activation (Bismuth Germanate, BGO), arising most probably from passive beam shaping
contaminations, the proposed detector conﬁgurations had to be tested in-beam. For that,
BGO was substituted with a state-of-the-art scintillator (lutetium oxyorthosilicate, LSO) and
two position sensitive detectors were built. Each detector contains 32 pixels, consisting of LSO
ﬁnger-like crystals coupled to avalanche photodiode arrays (APDA). In order to readout the
two detectors operated in coincidence, either in standalone mode or at the GSI medical beam
line, a multi-channel, zero-suppressing free, list mode data acquisition system was built. The
APDA were chosen for scintillation detection instead of photomultiplier tubes (PMT) due to
their higher compactness and magnetic ﬁeld resistance. A magnetic ﬁeld resistant detector is
necessary if the in-beam PET scanner is operated close to the last beam bending magnet, due
to its fringe magnetic ﬁeld. This is the case at the isocentric, ion beam delivery planned for
the dedicated, heavy ion hospital facility under construction in Heidelberg, Germany. In-beam
imaging with the LSO/APDA detectors positioned at small target angles, both upbeam and
downbeam from the target, was successful. This proves that the detectors provide a solution for
the proposed next-generation, improved in-beam PET scanners. Further conﬁrming this result
are germanium-detector-based, spectroscopic γ-ray measurements: no scintillator activation is
observed in patient irradiation conditions.
Although a closed ring or a dual-head tomograph with narrow gaps is expected to provide
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improved in-beam PET images, low count rates in in-beam PET represent a second problem
to image quality. More importantly, new accelerator developments will further enhance this
problem to the point of making impossible in-beam PET data taking if the present acquisition
system is used. For these reasons, two random-suppression methods allowing to collect in-beam
PET events even during particle extraction were tested. Image counts raised almost twofold.
This proves that the methods and associated data acquisition technique provide a solution for
next-generation, in-beam positron emission tomographs installed at synchrotron or cyclotron
radiotherapy facilities.
Objectives of this dissertation
The objectives pursued with the present work are the optimization of in-beam positron emis-
sion tomography applied for the monitoring of heavy ion tumor irradiation. This optimization
requires, in a ﬁrst step, identifying present or future limitations of in-beam PET. Present
limitations are those already existing at the in-beam PET installed at the GSI facility. Fu-
ture limitations are those expected to arise at in-beam PET to be installed onto heavy ion
tumor treatment facilities under planning or construction elsewhere. In a second step, the
understanding of the sources of those limitations is necessary. Based on this knowledge sev-
eral mathematical and technological innovative solutions are proposed, or extended from its
present status, constructed and veriﬁed, either by simulation or experimentally. In some cases,
discriminated below and throughout this dissertation, the understanding of the source of the
limitation is brought from reasearch work performed previously, or during the course of these
studies, by a second party. In these situations this work focuses on providing an overcoming
solution, based on that knowledge, as well as verifying it.
The most important limitation of in-beam PET, ﬁrstly addressed in this work, is the problem of
image artifacts arising from limited angle tomography. In order to study the origin of the several
artifacts and to be able to propose a detector conﬁguration that minimizes them, two software
tools were needed. These were a tomograph simulation, capable of handling several detector
conﬁgurations, and a ﬂexible reconstruction routine able of reading and treating mathematically
the ouput of this simulation. Reconstruction routines provided by conventional PET applied
to data sets of very low statistics yield images of poor quality. More importantly, they require
the tomograph to be space invariant, a requisite only met by closed ring detector geometries.
On the other hand, the reconstruction routine developed for the in-beam tomograph at GSI is
based on a ﬁxed histogram size. The size of this histogram is given by the product of the number
of detectors on both heads. This limits its application to tomographs with larger heads due to
two reasons. First, the histogram size increases almost two orders of magnitude as one moves
from the dual-head tomograph installed at GSI to a typical closed ring PET scanner. A ﬁxed
histogram strategy, if implemented, would be too demanding in terms of computer memory
and processing time. Second, the implementation of larger detector heads allows one valid
event to trigger two detectors in the same head, which cannot be considered by such histogram
strategy. Therefore, the development of a reconstruction routine that extends the mathematical
data treatment already implemented for the in-beam tomograph at GSI was necessary. This
extended reconstruction routine, applied onto larger tomographs, allows to study the source of
artifacts in limited angle tomography. In addition, it provides a reconstruction solution for a
future closed ring or dual-head, in-beam tomograph with smaller gaps (larger heads).
The optimum detector geometry for in-beam PET poses integration challenges when brought
onto heavy ion treatment sites. On one side such tomograph must be as ﬂexible as possible
in order to avoid collisions with the patient, its table and couch and with the beam delivery
system. This favors a small volume, dual-head tomograph solution. On the other side, in-beam
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PET images obtained with a limited angle tomograph loose quality in respect to those sampled
with closed ring ones. Technical solutions for implementing in-beam PET at future therapeutic
sites, with these variables properly considered, were also necessary not only for rotating beam
deliveries as well as for ﬁxed, horizontal beam lines. During the course of this work a technical
solution for implementing a dual-head, in-beam positron emission tomograph onto a rotating
beam delivery was developed at GSI by a second party. In addition to self developed integration
proposals, this work analyzes the advantages and disadvantages of the design of GSI and, in
addition, extends it by proposing the installation of a closed-ring tomograph.
Besides the limitations arising from limited angle tomography, in-beam PET images are also
aﬀected by low statistics data sets. Data taking during particle extraction is presently vetoed
due to the presence of a high noise background which overlaps the annihilation signal. A
correlation existing between the moment of arrival of background events with the arrival of the
carbon ions, synchronized with the accelerator radiofrequency signal, was found and exploited
by other members of this in-beam PET team. A technical solution applying this knowledge was
necessary in order to allow in-beam PET data taking during particle extractions. Such solution
was required for two reasons: (i) for increasing the statistics of the acquired images, and (ii)
for implementing in-beam PET at future facilities using optimized synchrotron or cyclotron
accelerators. This is because recent developments in accelerator technology result in beam
extraction times occupying close to 100% of the accelerator duty cycle.
Finally, the detector and data acquisition technology installed at the in-beam PET at GSI
is based on the solutions available at the time of its installation. Not only state-of-the-art
technology has outperformed the eﬃciency of the tomograph once installed, as well as the
special requirements of in-beam PET have been better understood. This must lead to dedicated
in-beam PET solutions that diﬀer from conventional tracer imaging technology. With this
objective set, proposing and testing modern γ-ray detectors and data acquisition strategies
directly optimized for in-beam PET was also a need. A new detector solution was also necessary
in order to overcome the limitation of the current detectors if operated in close vicinity to fringe
magnetic ﬁelds. Such ﬁelds, generated by the last beam bending magnet, will be present if
in-beam PET is installed onto isocentric, rotating beam deliveries.
Outline
This dissertation, Optimization of In-Beam Positron Emission Tomography for Monitoring
Heavy Ion Tumor Therapy, lies within the framework of the Heavy Ion Tumor Therapy Col-
laboration. In order to introduce the term in-beam PET into its context, chapter 1 summarizes
the motivations inherent to conformal radiotherapy and the present clinical results of charged
particle radiotherapy. The physical and radiobiological rationale for carbon ions are then
presented and its clinical impact is brought up by including, from the literature, treatment
planning comparisons of carbon ions both with photons and with protons. Concerning heavier
ions, a summary of previous, pioneering trials elucidates why carbon ions are advantageous.
Finally, the principles and capabilites of in-beam positron emission tomography are described,
together with the technical solution implemented by the team from FZR at the facility in GSI
in order to monitor the carbon ion patient irradiation.
The aim of chapter 2 was to optimize the detector geometry for in-beam PET. A fully 3D,
maximum likelihood expectation maximization algorithm applicable to several closed ring or
dual-head tomographs shows the possible sources of image artifacts in limited-angle tomo-
graphy. The analysis of β+-activity distributions simulated from real-treatment situations and
detected with several detector arrangements allows to conclude that a dual-head tomograph
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with narrow gaps yields in-beam PET images with suﬃcient quality for monitoring head and
neck treatments. For monitoring larger irradiation ﬁelds, e.g. treatments in the pelvis region,
a closed ring tomograph was seen to be highly desirable. In the last section of this chapter a
study of the space availability for patient and bed, tomograph and beam portal, proves viable
the implementation of a closed ring detector geometry for in-beam PET.
Chapter 3 analyzes three proposals for in-beam PET integration into space-constrained treat-
ment rooms due to the presence of an isocentric, rotating beam delivery. They are: PET at the
patient couch, PET on a separate gantry and PET at the beam nozzle. It concludes that the
conﬁguration with PET at the beam nozzle, developed at GSI, not only satisﬁes most integra-
tion requisites but also oﬀers the possibility of integrating a closed ring tomograph, therefore
greatly beneﬁting the quality of forthcoming in-beam PET images. The integration of in-beam
PET onto ﬁxed, horizontal beam lines is also studied.
In chapter 4 the operation parameters of two state-of-the-art scintillation detection devices are
optimized. The detectors consist of ﬁnger-like LSO crystals coupled to APDA. The substi-
tution of PMT by APDA provides the magnetic ﬁeld resistance and compactness needed for
the next-generation, in-beam PET detectors, as described. The energy and time resolutions
measured, better than those obtained with the presently installed detectors, are directly related
to the quality of PET images. Further studies presented in this chapter provide quantitative
eﬃciency and acceptance results used in the normalized images and depth-proﬁles presented
in the following two chapters.
The in-beam imaging capability of these LSO/APDA detectors operated under or after harsh
irradiation conditions are described in chapter 5. In one experiment the detectors were posi-
tioned up and downbeam from a target irradiated with a ﬂuence equivalent to 1 000 typical
daily therapeutic fractions. A line source positioned between the detectors was imaged, allow-
ing parameters like time, energy and spatial resolution to be compared before, during and after
irradiating the target. A second experiment imaged the β+-activity distribution generated by
a monoenergetic beam in a target of Lucite. In addition, a third experiment exposed a scin-
tillator block of LSO to the ﬂux of light particles leaving two single-portal patient treatments.
Germanium-detector-based, spectroscopic γ-ray measurements showed no scintillator activa-
tion. Due to the small amount of 176Lu, a natural radioactive isotope, in LSO, the inﬂuence of
the natural background activity density of LSO onto an LSO-based tomograph was estimated.
It is seen that, in order not to compromise the quality of the low-statistics in-beam PET images,
modern, digital data acquisition techniques are necessary in order to reduced the coincidence
time resolution of the detectors. Finally, the impact of recent developments in ultra-fast timing
detectors, potentially allowing the implementation of the time-of-ﬂight technique onto commer-
cial PET scanners, was extrapolated to in-beam PET. Very promising results can be achieved
for tomographs with a coincidence time resolution below 200 ps FWHM.
In chapter 6 two random-suppression methods allowing to collect in-beam PET events even
during particle extraction were tested, raising image counts almost twofold and providing a
data acquisition solution for next-generation, in-beam positron emission tomographs installed
at synchrotron and cyclotron beam lines. The two LSO/APDA detectors were used and the
2D images and depth proﬁles obtained during particle extraction clearly show the feasibility of
both methods proposed.
The conclusions from this dissertation, together with future work suggestions, are presented in
chapter 7.
Chapter 1
Radiotherapy with Carbon Ions
1.1 Motivation
Cancer is one of the major causes of death in modern society, ranking second after heart
and circulatory diseases. At the time of diagnostics, about 58% of tumors have not spread to
distant locations, i.e. have not formed metastases (Fig. 1.1). Tumors at this localized stage can
potentially be cured by local interventions - surgery, radiation therapy or a combination of both.
About 22% of all cancer patients are cured by surgery. Presently available radiotherapeutic
methods can cure 12%, while another 6% receives a combination of surgery and radiotherapy.
Figure 1.1: Presently used cancer treatment methods, after [GSI99a].
However, current local or loco-regional tumor treatment modalities in the European Union
fail for 18% of all cancer patients, which represents about 280 000 deaths per year [Sch96c].
This is due to the impossibility of removing the tumor in total or applying a radiation dose
high enough to sterilize all cancer cells [Sch03b]. If not all, a great part of these patients
could be cured successfully if localized tumor treatment techniques, like radiotherapy, would
be improved. The heavy ion tumor therapy pilot project, currently running at the Gesellschaft
für Schwerionenforschung1 (GSI) Darmstadt, is among the best examples of this improvement:
since December 1997 over 250 patients with radioresistant tumors in the head and neck region
as well as in the pelvis were treated with high energy carbon ions yielding very promising
clinical results [Deb00, Sch02b, Sch03b]. The aim of the pilot project is to exploit the physical
1 Laboratory for Heavy Ion Research
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and radiobiological advantages of carbon ions for high precision radiotherapy [Kra90], allowing
radioresistant tumors growing in close vicinity to organs at risk (OAR) to be irradiated. In
a ﬁrst stage, only slow-growing, non-metastasic tumors of the head, neck or spinal chord are
selected, namely
- skull base tumors: chordoma, chondrosarcoma, malignant schwannoma atypical meningeoma,
adenoidcystic carcinoma, and
- tumors close to the spinal chord: sacral chordoma, chondrosarcoma, and soft tissue sarcoma.
An example of the ﬁrst clinical results is shown in Fig. 1.2. Further results show that carbon
ion irradiation is feasible and safe with no severe acute radiation-induced toxicity [Sch02a].
Figure 1.2: First results from the clinical study showing the course of disease of a female patient
before (left) and six weeks after therapy at GSI (right), from [GSI99b]. As a result of the strong
recession of the tumor located in the base of the skull region, the symptons of paralysis have
almost completely disappeared.
A compilation of therapy results from this study as well as from other hadron therapy facilities is
shown in Table 1.1, together with results achieved with conventional photon therapy. Although
tumors other than chondromas and chondrosarcomas are handled at GSI, they occur more
seldom so the study is ongoing with preliminary results discussed elsewhere [Sch04, Sch03c].
The trend in clinical eﬀectiveness by using charged particles can clearly be seen. In order to
arrive at this motivating stage, over 50 years have passed since physical and radiobiological
research with ion beams was initiated at the Lawrence Berkeley National Laboratory (LBNL) in
1947, only one year after R. Wilson had proposed the use of ion beams for therapy due to their
superior depth dose distribution [Wil46]. An historical evolution is described in [Kra00]. The
improved results nowadays achieved at the treatment facility at GSI are due to the following
scientiﬁc and technological developments:
- excellent 3-D beam conformity through an active beam delivery system by means of the
intensity controlled rasterscan technique [Hab93],
- inverse treatment planning [Krä00] based on the GSI-developed radiobiological model, the
local eﬀect model LEM [Sch96d] and
- the use of positron emission tomography (PET) for in-situ monitoring the particle localiza-
tion [Eng04b].
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Table 1.1: Hadron therapy results from multi-center studies according to [Kra00]. GSI results
after [Sch03b].
Indication End- Results Results Res.
point photons hadrons GSI
Nasopharyngeal carcinoma 5y-S 45-50% 63%
(advanced stage)
Chordoma LCR 30% 65% 87%
Chondrosarcoma LCR 33% 88% 100%
Blastomatous glioma AST 12 months 16.9 months
Malignant meningioma PFSR 30% 85%
Uveal melanoma 5y-S 95% 96%
loss of eye maintenance of vision
Tumors of the paranasal sinuses LCR 21% 63%
Pancreatic carcinoma AST 6.5 months 7.8 months
Liver tumors 5y-S 23% 100% (HIMAC)
Cervix uteri (stage IIIB) LCR 66% 73% (neutron boost)
Urinary bladder carcinoma DS 30% 50% (neutron boost)
Prostate (C, D1) LCR 31-68% 89% (neutrons)
Salivary glands LCR 24-28% 61%
Soft tissue carcinoma 5y-S 31-75% 52-83%
LCR: Local Control Rate PFSR: Progression Free Survival Rate
DS: Down Staging AST: Average Survival Time
5y-S: 5-year Survival rate HIMAC: Heavy Ion Medical Accelerator in Chiba, Japan
Based on this pilot project and incentivated by its promising results, the institutions that take
part in it1 have made a proposal for a dedicated hospital-based ion beam facility for cancer
therapy to be built in Heidelberg, Germany. This facility, expected to be operational in 2006,
will have a treatment throughput of 1000 patients per year with a wider spectrum of treatable
tumors. It will, furthermore, provide beams ranging from proton to oxygen ions thus enabling
further clinical studies to be performed.
1.2 Physical Rationale for Carbon Ions
Beams of heavy charged particles like protons or heavy ions2, like carbon, represent the opti-
mum tool for the treatment of deep seated, inoperable and radioresistant tumors growing in
close vicinity to organs at risk [Wil46, Kra90]. In contrast to conventional photon therapy, the
dose deposited by heavy charged particles increases with the penetration depth, culminating
in a sharp maximum at the end of the particle range - the Bragg peak (section 1.2.1). In
order to achieve a precise tumor-conform irradiation, the Bragg maximum can be shifted in
depth by energy variation and distributed laterally through magnetic deﬂection of the particle
beam (section 1.2.2). In addition to these excellent physical selectivity, the biological eﬃciency
concerning cell killing increases towards the end of the trajectory of the carbon ion. Therefore,
the increase in dose at the Bragg peak is further enhanced by an increase in biological eﬃ-
1 The Radiologische Universitätsklinik Heidelberg (project coordinator), the Deutsches Krebsforschungszen-
trum Heidelberg (DKFZ) and the Gesellschaft für Schwerionenforschung Darmstadt (GSI) in cooperation
with the Forschungszentrum Rossendorf (FZR), Dresden.
2 Ions heavier than protons are called heavy in radiobiology [Kra00], as opposed to nuclear physics terminology,
due to their increased biological eﬀectiveness (section 1.3).
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ciency (section 1.3). Finally, nuclear fragmentation reactions between the 12C projectiles and
atomic nuclei in the target volume create a small amount of β+ emitters, mostly 11C, 15O and
10C, which allow an in-situ dose localization control by using positron emission tomography
techniques (section 1.4).
1.2.1 Passage of charged particles through matter
The depth dose proﬁle exhibited by heavy charged particles is due to its ways of interacting
with matter.
Electronic energy loss
Moderately relativistic1, charged particles other than electrons lose energy in matter primarily
by ionization. The mean rate of energy loss, or stopping power, is given by the Bethe-Bloch
equation [Hag02, Leo94]
−dE
dx
= Kz2eff
Z
A
1
β2
[
1
2
ln 2mec
2β2γ2Tmax
I2
− β2 − δ
2
]
(1.1)
with Tmax the maximum kinetic energy which can be imparted to a free electron in a single
collision and the other variables deﬁned in Table 1.2.
Table 1.2: Variables and values of the Bethe-Bloch equation according to [Hag02].
Symbol Deﬁnition Units or value
dE
dx energy loss MeVg−1 cm2
A atomic mass of medium gmol−1
NA Avogadro's number 6.022 136 7(36)× 1023mol−1
K
A 4piNAr2emec2/A 0.307 075 MeVg−1 cm2
for A = 1 gmol−1
zeff eﬀective charge of incident particle
Z atomic number of medium
mec2 electron rest energy 0.510 999 06(15) MeV
I mean excitation energy eV
δ density eﬀect correction
The values for the mean excitation energy I adopted by the International Commission on
Radiation Units and Measurements (ICRU) for the chemical elements [ICR84] are now in
wide use. Within the range of therapeutic relevant energies, below several hundreds of AMeV
for carbon ions, Tmax = 2mec2β2γ2 and the stopping power scales down with ∼ 1/β2 with
increasing energy. The relativistic term δ/2 in the Bethe-Bloch equation (density eﬀect) is
negligible and radiative processes do not take place.
Fig. 1.3 shows the stopping power for positive muons in copper for a wide range of projectile
energies so that the limits of validity of the Bethe-Bloch equation can be seen. These limits
depend both on the eﬀective atomic number of the absorber and the mass of the particle slowing
down [Hag02].
At lower energies corrections for tightly-bound atomic electrons (shell correction) and other
eﬀects must be made. Among these is the Barkas eﬀect which explains the higher stopping
power observed for positive charged particles, e.g. the µ, pi and proton, in respect to their
1 Particles with a velocity ranging between 10% and 99% of the speed of light, approximately.
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Figure 1.3: Stopping power for positive muons in copper as a function of βγ = p/Mc, af-
ter [Hag02]. Data below the break at βγ ∼ 0.1 are taken from ICRU49 [ICR93] and at higher
energies from [Iva98]. For 0.01 < β < 0.05 there is no satisfactory theory. For protons, empirical
ﬁtting formulae were developed by Andersen and Ziegler. For β ≤ 0.01 (more or less the velocity
of the outer atomic electrons), Lindhard has been able to describe the stopping power, which is
proportional to β. At even lower energies, non-ionizing nuclear recoil dominates the total energy
loss [Zie85]. The "µ−" curve illustrates the Barkas eﬀect described in the text.
negative counterpart [Zie99] due to the polarization of target electrons onto and away from the
positive or negative projectile, respectively. A detailed discussion of low-energy corrections to
the Bethe-Bloch formula is given in [ICR93]. Of main importance for heavier ions is the fact
that at lower velocities a positive projectile starts collecting electrons from the surrounding
target material, thus decreasing its eﬀective charge zeff . The correlation between the velocity
of the projectile β and zeff is given by the Barkas formula [Bar56]
zeff = z(1− e−125βz2/3). (1.2)
The dominant part in the Bethe-Bloch valid regime is the 1/β2 factor and the zeff dependence.
The 1/β2 factor yields an increase in energy loss with decreasing energy: 1/β2 ∼ 1/E. This
can be seen in Fig. 1.4 for several ions, with the stopping power displayed with units of linear
energy transfer (LET∞=LET), a measure of the energy deposited in the target by all electrons
ejected by the passing particle. If LET100 would be used, for example, then only those electrons
ejected with energies inferior to 100 eV would be considered (restricted stopping power).
When the energy loss of a charged hadron is plotted versus its penetration depth, its maximum
- the Bragg peak - is located at the end of the track. Fig. 1.5 shows this eﬀect for carbon ions
in water with diﬀerent energies and with the energy loss converted to units of relative dose.
In radiobiology and therapy the absorbed dose D, with unit Gray (Gy), is deﬁned as the
energy deposited in the target per mass unit [ICR70], i.e. 1Gy=1 J kg−1. If a thin volume
- thin compared to the energy loss of a particle - is irradiated by a parallel beam of particles
with ﬂuence F the dose imparted into this volume is
D [Gy] = 1.6 · 10−9 · dE
dx
[
keV
µm
]
· F
[
1
cm2
]
· 1
ρ
[
cm3
g
]
. (1.3)
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Figure 1.4: Energy loss in water for several particles, after [Sch91]. The curves were calculated
with the computer code ATIMA (atomic interactions with matter).
Figure 1.5: Depth dose proﬁles for photons and carbon ions with diﬀerent energies, after [Kra00].
The low energy loss of charged particles at higher energies, shown in Figs. 1.3 and 1.4, yields
the nearly constant dose plateau in the entrance channel in Fig. 1.5. Such depth-dose proﬁle is
optimum for the treatment of deep-seated tumors, as ﬁrst noted by R. Wilson in 1946 [Wil46].
Multiple scattering and range straggling
A charged particle traversing a medium is deﬂected by many small-angle scatters. Although the
strong interactions also contribute to this phenomenon, most deﬂections are due to Coulomb
scattering with target nuclei, hence the eﬀect is called multiple Coulomb scattering (MCS). As
conﬁrmed by proton measurements [Got93], the theory of Molière [Mol48] describes precisely
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the Coulomb scattering distribution. It is roughly Gaussian for small deﬂection angles and it
shows larger tails like Rutherford scattering for larger ones. For small angles θ it is suﬃcient
to use a Gaussian approximation with an angular width given by [Hig75, Hig79, Lyn91a]
σθ =
13.6MeV
βpc
z
√
x/X0
[
1 + 0.038 ln ( x
X0
)
]
, (1.4)
with p, βc and z the momentum, velocity and charge of the projectile and x/X0 the thickness of
the scattering medium in radiation lengths1. For very heavy ions MCS has been compared with
various theoretical distributions [Won90]. A compilation of results of MCS of heavy charged
particles pertinent to therapy applications is presented in [Lit68].
The eﬀects of MCS on the lateral broadening of beams of protons and carbon ions are shown in
the top graph of Fig. 1.6. The lateral spreading of a photon beam is also shown for comparison.
It can be clearly seen that protons exceed the lateral spreading of the photon beam after 7 cm
penetration, whereas the deﬂection of the carbon beam is less than 1 mm up to a penetration
depth of 20 cm. Beam lateral spreading plays an important role in treatment planning, mostly
when high doses are needed (tumor) in close vicinity to low dose regions (healthy tissue, organs
at risk). Examples of treatment planning comparisons between carbon ions and photons as
well as protons and photons are given in sections 1.2.2 and 1.2.3, respectively.
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Figure 1.6: Lateral spreading of a photon, carbon and proton beam in water (top) and the
corresponding relative depth-dose proﬁles (bottom), after [Web96]. Despite the initial diﬀerence
in beam widths, a lower lateral scattering among the charged species is veriﬁed for carbon ions.
The dose-proﬁles on the bottom graph in Fig. 1.6 show a sharper Bragg peak at 14.5 cm for
carbon ions versus protons due to the lower range straggling of heavier projectiles. The range
R of a beam of monoenergetic charged particles with energy E is deﬁned as the penetration
1 Mean distance over which a high-energy electron loses all but 1/e of its energy by bremsstrahlung [Hag02].
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depth at which half of its initial particles have already stopped. If the ionization energy loss
were a continuous process a sharp fall-oﬀ of the beam would occur at
R =
∫ 0
E
1
dE/dx
dE, (1.5)
which is not the case because the ionization process is stochastic and, furthermore, diﬀerent
MCS processes yield diﬀerent paths for the beam constituents. Therefore, the calculated value
R represents the mean range with a Gaussian distribution with the form [Boh15, Ahl80]
G(x) =
1√
2piσx
exp(x−R)
2
2σ2x
(1.6)
where x is in the beam direction and
σ2x = 4pi
Z2eff
Z2
N∆x
[
1− β2/2
1− β2
]
. (1.7)
In water this width can be approximated to [Chu99]
σx = 0.0120
R0.961√
A
. (1.8)
This formula is valid in the range 2 cm≤R≤ 40 cm. The value of σx (cm) is almost proportional
to R and is inversely proportional to
√
A. For example, for a range of 20 cm in water σx=0.2 cm
for protons, 0.1 cm for helium, 0.06 cm for carbon and 0.046 cm for neon ions. However, in
practice range proﬁles are determined rather by the density distribution of the penetrated
tissue than by the intrinsic projectile straggling. For small penetration depths (R<10 cm in
the case of carbon ions delivered with active scanning - section 1.2.2), the half width of the
Bragg maximum frequently has to be increased artiﬁcially with a passive absorber (ripple ﬁlter)
in order to reduce the overall treatment time since, if the Bragg peak is too sharp, too many
energy steps would be needed in order to ﬁll the the target volume [Web96, Kra00].
Nuclear fragmentation
Heavy-ion nuclear reactions can be classically divided into three large classes: central collisions,
peripheral collisions and various Coulomb force induced processes also named distant or barrier
processes [Kau61, Nör80]. The impact parameter1 b is responsible for this classiﬁcation. At
beam energies corresponding to approximately the Coulomb barrier2 both barrier processes and
central collisions take place, the latter forming only compound nuclei at these low energies. If
b is relatively large the Coulomb barrier is not penetrated, giving rise to barrier processes like
Rutherford scattering, Coulomb excitation [Alk56], nucleon transfer by tunneling [Rey56] and
other combinations of these processes [Bre56]. The eﬀects of Rutherford scattering (the only
elastic collision) on the beam lateral broadening were described in the previous section (MCS).
At smaller b the projectile can penetrate the Coulomb barrier but at the moment of contact
with the target it has very little kinetic energy. A compound system is formed (fusion) which
decays at some subsequent time3. The angular cross sections for emitted products of barrier
processes peak at some angle for each bombarding energy and the peaks move to smaller angles
with increasing energy [McI60].
1 Distance b between the trajectories of the centers of two colliding nuclei (Fig. 1.7).
2 Value of the Coulomb potential when the two nuclei are at a distance corresponding to the sum of their
radii: VCoul = 14pi²0
Z1Z2e
2
r
, with r = 1.4× [A1/31 +A1/32 ].
3 This regime is used to search for super heavy nuclei. At GSI and LBNL cold fusion is used, whereas the
Joint Institute for Nuclear Research (JINR), in Dubna, Russia, uses hot fusion methods [Hof00].
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When the beam energy is well above the Coulomb repulsion between projectile and target,
nuclear fragmentation gradually takes place and the contribution of elastic scattering decreases
[Won94]. This is the case with the incoming energies for therapy with carbon ions (85 to
430AMeV). Because of its high-energy the projectile comes in contact with the target nucleus
and, as a consequence of the geometry of the reaction in this energy regime (Fig. 1.7), central or
near central collisions account for about 10% of all nuclear fragmentation events [Sih93, Oli79].
At these energies, central collisions are characterized by multifragmentation, i.e. the blow-up
of the reaction partners into many fragments distributed over a wide range of angles [Oli79].
Peripheral collisions, therefore, constitute the major source of events of nuclear fragmentation.
Figure 1.7: Scheme of a peripheral nuclear collision according to the abrasion-ablation model.
Most peripheral collision models today are based on the concept of nuclear abrasion-ablation
[Oli79] depicted in Fig. 1.7. The target and projectile overlap only partially and, depending
on the impact parameter and the sizes of the nuclei, a ﬁreball is formed (abrasion, ∼ 10−23 s)
with all overlapping nucleons (participants). Due to the high velocity of the reaction, the
remaining projectile and target nucleons can be considered not to take part in the reaction
(spectators). Consequently, the ﬁreball travels along the beam direction with less kinetic
energy per nucleon (it contains nucleons both from projectile and target), whereas the projectile
fragment remains large and travels almost with the same velocity of the original projectile. In a
second step (∼ 10−21 to 10−16 s) the excitation energy in the fragments and ﬁreball is released
by evaporation (ablation) of nucleons. When the energy of the excited products falls below the
nucleon separation threshold the emission of γ-rays takes place (chapter 6).
Peripheral collisions result in fewer particles (compared to central collisions) observed in the
forward cone of laboratory angles [Gun04a, Gun04b]. They include both charge-changing
(projectile loses one or more protons) as well as non-charge-changing (loss of one or more
neutrons) reactions. Both reactions have utmost importance on the physical dose distribution.
Charge-changing reactions produce lower-Z particles which have longer ranges and deliver an
unwanted dose beyond the Bragg peak of the original projectile. Non-charge-changing reactions
produce lower-A isotopes which stop before the original projectile (range scales with A/Z2 at
same velocity).
In order to correctly account for the dose contribution of all intervening particles, fragmentation
measurements were performed in Berkeley for neon [Sch89] and at GSI for carbon ions [Sch96a,
Sch96b] among other species. Fig. 1.8 shows the results for several projectiles. The bottom
row of Fig. 1.8 shows that the fragmentation of 16O yields more C6+ nuclides than N7+.
This is due to selection rules that prevent the abundance of the diﬀerent fragments from
decreasing monotonously with atomic number [Kra00]. In the same row it is possible to see
a slight inversion of the number of fragments for higher penetration depths, corresponding
to fragmentation reactions of the fragments themselves into further lower-Z particles. This
contributes to the high yield of low-Z fragments shown in the middle row (curve with Z ≤ 4).
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Figure 1.8: Fragmentation measurements for oxygen, neon and carbon ions with 670AMeV,
after [Sch96b]. Top row shows the attenuation of the original projectiles. The middle and bottom
rows show the buildup of lower-Z fragments.
In general, beam fragmentation tends to deteriorate the sharp dose contours by enhancing
lateral and longitudinal scattering. This is a minor problem at the entrance channel - high
energies - but becomes more important at the tail of the Bragg peak. Fragmentation products
restrict the use of an absorber material (section 1.2.2) in the beam. Fig. 1.8 also shows an
increase in the number of fragments with increasing projectile size and charge. For heavier ions,
the undesirable amount of fragments produced is further enhanced (e.g. neon, section 1.2.3).
The knowledge of the ﬂuences F of the several nuclear fragmenation projectiles Nz reaching
the target volume at r with density ρ is necessary in order to calculate the total dose:
Deq(r) =
Nz∑
z=1
∫ E
0
F (z, E, r) · LET (z, E) ·RBE(z, E) · 1
ρ(r) dE. (1.9)
Deq denotes the equivalent dose since the physical dose deposited at each location r is weighted
by its relative biological eﬀectiveness RBE (section 1.3).
Finally, nuclear fragmentation may result in radioactive projectile and target fragments de-
exciting by β+ decay. A tremendous advantage to radiotherapy is opened by using imaging
techniques like positron emission tomography (PET) to measure this β+ activity, since it is
highly correlated with the incoming beam (section 1.4).
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1.2.2 Advantages in comparison to photons
The main physical advantage in radiotherapy when heavy charged particles are compared to
photons arises from the diﬀerent depth-dose proﬁles of the two species, as shown in Fig. 1.5.
The proﬁle exhibited by photons is due to the physics processes through which electromagnetic
radiation interacts with matter, namely
- photoeﬀect: the photon is absorbed and an atomic electron ejected;
- incoherent (Compton, inelastic) scattering: the photon is scattered and an atomic electron
ejected, this is the main process at radiotherapeutical relevant energies;
- coherent (Rayleigh, elastic) scattering: the photon is deﬂected from its trajectory but the
target atom is neither ionized nor excited;
- pair production: disintegration of a photon into an electron-positron pair due to an interac-
tion with the nuclear ﬁeld, or with the ﬁeld of the atomic electrons; and
- photonuclear absorption: nuclear absorption, usually followed by emission of a neutron or
other particle.
Fig 1.9 exempliﬁes how the individual processes are depending on the photon energy for a
carbon target. Although for water, tissue and denser organic material the cross sections are
diﬀerent, the ratio between the diﬀerent processes does not change dramatically. Therefore, it
can be seen that within the typical energy ranges for photon radiotherapy (∼ 4 to 50 MV) the
main physical process contributing to the dose is the Compton eﬀect. For diagnostic imaging
(X-rays), much lower energies are used and the photoeﬀect plays also an important role.
Although the number of penetrating photons in an incoming beam decreases exponentially with
the target depth, the photon depth-dose proﬁle in Fig. 1.5 ﬁrst shows a slight increase and only
after an energy-dependent peak it starts falling exponentially. This is due to the fact that
Figure 1.9: Cross sections for photon interactions in carbon, after [Gro98b], with
σp.e.=photoeﬀect, σcoherent=coherent scattering, σincoh= incoherent scattering, KN =pair pro-
duction (nuclear ﬁeld), Ke=pair production (electron ﬁeld) and σnuc=photonuclear absorption.
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the Compton released electrons are strongly forwardly peaked so that the energy transferred
into the target is transported a few centimeters deeper into the direction of the beam (build
up). For this reason dose calculations for photon therapy do not use the photon attenuation
coeﬃcient but the photon energy-absorption coeﬃcient (absorbed dose).
Another physical disavantage of radiotherapy with electromagnetic radiation when compared to
carbon ions is the higher beam lateral broadening with photons. Lateral scattering of charged
particles was discussed in section 1.2.1 and its consequences onto treatment planning with
carbon ions and with protons are presented in sections 1.2.2 and 1.2.3, respectively.
Beam shaping: the importance of the rasterscan technique
One important advantage besides the depth-dose proﬁle of charged hadrons in regard to photons
is the possibility to drive a charged beam by using magnetic deﬂection. Despite being a technical
challenge due to the high energies required to make a charged beam penetrate deep enough
into tissue and bone (e.g. a 400 AMeV 12C beam penetrates 27.3 cm in water), this principle
avoids all the passive shaping components in the path of the beam described below.
Beam shaping for photons: Although a method for active shaping of scanned high-energy
photon beams has been proposed [Sve98], only passive beam shaping, depicted in Fig. 1.10,
has been used to date for simplicity reasons. X-rays (characteristic and bremsstrahlung) are
produced by hitting high energy electrons (after the accelerating waveguide) in the radiator
target. The photons are emitted primarily in the forward direction, but also laterally and
backwards. At the primary collimator - a block of high density metal e.g. tungsten - laterally-
produced X-rays are attenuated. A uniform intensity across the beam is later produced at the
beam ﬂattening ﬁlter. The ionization chambers provide a current proportional to the absorbed
dose rate of the treatment beam in the patient (or a tissue-equivalent phantom). Feedback
systems automatically adjust the electron beam current in the accelerating waveguide and
beam steering current, to ensure constant treatment beam output and uniformity. Finally,
the wedge ﬁlter can be used to modify the intensity of the X-ray photon beam in one plane
to shape the isodose distribution around a target volume. Older linear accelerators (LINAC)
may have manual wedge ﬁlters of varying thicknesses. Some LINAC use a dynamic wedge or
ﬂying jaw technique to give the eﬀect of a wedged beam using precise computer control of
jaw movement. In newer systems, able to deliver intensity modulated radiotherapy (IMRT), a
Figure 1.10: Diagram of a photon treatment head, after [Lin05].
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dynamic multileaf collimator consisting of 20 or more thin collimator plates is used to obtain
irregularly-shaped ﬁelds that conform to the target volume.
Passive beam shaping for hadrons: Both passive and active beam shaping have been
implemented in charged hadron radiotherapy. The width of the Bragg peak and the lateral
dimensions of a particle beam are usually much smaller than the tumor volume to be treated.
Therefore, the beam has to be spread in lateral and longitudinal direction in order to ﬁll the
target volume as preciselly as possible. Tumor conformity is an issue in order not to damage
healthy tissue, but special care must also be taken in order to avoid cold spots (local regions
with lower dose) in the target since an underkill there corresponds to a tumor regrowth center.
Fig. 1.11 depicts the principle of passive shaping for heavy ions. The accelerator produces a
beam of ﬁxed energy which is laterally spread at the scattering system. At this stage the dose
proﬁle corresponds to a pristine Bragg-peak. To overlay the dose over the whole extension
of the tumor a range modulator together with a range shifter degrade the spatial resolution
of the pristine peak and assure that the overlay of several Bragg-peaks produces a so-called
spread-out Bragg peak (SOBP). A compensator, manufactured for each patient1, is responsible
for ﬁnally adapting the beam shape to the tumor volume avoiding dose delivered at the several
OAR. A detailed review of beam shaping systems is given in [Kra00].
Figure 1.11: The principle of passive beam shaping, after [Reg02].
Besides requiring a compensator being built for every patient and being limited in volume con-
formity, passive shaping also needs higher beam intensities, when compared to active shaping
described below, because a major part of the primary beam is wasted in apertures and blocking
devices. This, furthermore, produces a large amount of mostly forwardly scattered neutrons
and neutron-induced contaminations with its biological and technological drawbacks like, for
example, the activation of nearby imaging devices (section 1.4).
Active beam shaping: Excellent 3D beam conformity through an active beam delivery system
has been achieved at GSI by means of the intensity controlled rasterscan technique [Hab93].
The target volume is dissected into layers of equal particle energies (Fig. 1.12) and a small pencil
beam moves in each layer along a continuous path from one pixel to the next one2 by making
use of the depicted fast magnetic system. The particle ﬂuence is measured for each pixel and
1 An individual range modulator may also be necessary.
2 This is the rasterscan principle. The voxelscan principle (also called spot scanning, section 1.2.3) applied at
the Paul Scherrer Institute (PSI) in Switzerland shuts oﬀ the proton beam between each pixel [Ped95]. There,
depth conformity is achieved by means of a range shifter, i.e. the scatterers, collimator and compensator of
Fig. 1.11 are avoided.
14 Chapter 1. Radiotherapy with Carbon Ions
the beam is switched to the next pixel when the intensity for one position has been reached.
If the irradiation of one energy slice is complete the beam is switched oﬀ and the next, higher
energy is requested from the accelerator. With an accelerator duty cycle of approximately 40%
(2 s spill extraction with a macropulse period of 5 s, detailed in section 1.4.2 and chapter 6),
the GSI scanning system is able to deliver, from macropulse to macropulse, carbon beams
ranging from 80 to 430 AMeV with 252 energy steps, corresponding to ranges in water between
2 and 30 cm, respectively. In addition, the beam intensity and diameter can be changed in
the same mode. This is usefull because larger tumors can be treated faster with a larger beam
spot while small tumors or tumors very close to critical structures can be handled with smaller
beam sizes.
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Figure 1.12: The principle of the raster scanning technique, after [Hab93].
Not shown in the picture but also of great importance is the beam diagnosis system imple-
mented between the last steering magnet and the patient. Two multiwire proportional chambers
(MWPC) constantly verify the beam position while three ionization chambers read continously
the beam intensity being delivered [Bad97]. This information is fed into the magnet control
unit so that in the case of an unexpected deviation an interlock (beam switched oﬀ) is achieved
within half a millisecond [Hab93].
Treatment planning comparison: carbon ions versus IMRT
To compensate for the unfavorable, exponentially-decaying dose proﬁle of photons in radio-
therapy the patient is irradiated from several directions (portals) in order to accumulate a
higher dose in the tumor and spare the surrounding healthy tissue. Nevertheless, even with
state-of-the-art photon radiotherapy techniques like IMRT it can be seen that the degree of
tumor conformity is much higher for ions, as exempliﬁed in Fig. 1.13 for a head tumor and
described in more detail in [Sch03a] for spinal chordomas. The high conformity achieved with
carbon ions is due not only to the physical and radiobiological characteristics of the ions, but
also to the excellent beam delivery described above.
1.2.3 Advantages in comparison to other charged particles
In the previous section the physical advantages of charged hadron therapy were compared with
electromagnetic radiation. Within the spectrum of charged particles, though, the question of
which one performs better is not so easy to answer since all present an inverse depth-dose
proﬁle and all can be steered by magnetic scanning.
1.2. Physical Rationale for Carbon Ions 15
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Figure 1.13: Comparison of dose conformity with carbon ions versus IMRT for the same patient,
from [Wey03], courtesy of Oliver Jäkel, PhD. The 10 color levels indicate iso-dose lines starting
from 5% (blue) to 95% (red) of the maximum dose. A signiﬁcantly higher dose is delivered to
normal tissue with IMRT. Also, a much better conformity is achieved at the brain-stem (organ at
risk) in the case of the carbon treatment.
Protons
The ﬁrst use of protons in therapy was performed at the Berkeley 184-inch synchrocyclotron
[Tob52] in 1952, for pituitary1 treatments. Rotational therapy (twisting the head about the
pituitary as a center of rotation) was used with a high energy beam in order to avoid stopping
the beam due to the uncertainty in the tissue-thickness along the beam track. The ﬁrst Bragg-
peak therapy was performed in 1956 at Uppsala with a 230 MeV synchrocyclotron [Lar63]. In
1965 the 170 MeV synchrocyclotron at Harvard was converted into a dedicated medical facility
and became the site for the longest running program in radiosurgery and therapy with protons.
To date, over 30 000 patients have been treated at these and other newer facilities, with protons
being the most used charged particle cancer treatment modality due to the lesser complexity
of a proton radiotherapy facility [Kra00].
Although the answer to which modality performs better cannot be complete without addressing
radiobiology (section 1.3), a physical advantage of carbon ions over protons was already pointed
out in section 1.2.1, i.e. ions suﬀer less Coulomb scattering from target atomic nuclei due to
its larger mass and therefore momentum, thus enabling sharper gradients to be delineated.
However, nuclear fragmentation of the projectile, which does not happen with protons, enhances
the dose beyond the Bragg peak (Fig 1.6). For this reason, despite the low physical dose, and
due to possible range uncertainties induced by anatomical density irregularities along the beam
path, treatment planning with carbon ions should be careful when stopping the beam just before
any critical structure.
Two treatment planning comparisons between passively shaped protons and actively scanned
carbons ions are discussed in [Jäk02]. Important conclusions regarding dose conformity can be
drawn. For example, for a patient with a clivuschordoma the dose in the target volume is more
homogeneous when delivered with carbon ions, with a maximum/minimum ratio of 99% / 69%
versus 102% / 51% for passive conformed protons. In summary, dosage of OAR is reduced and
irregular tumors can be much better delineated with active delivered carbon beams. This work
1 The pituitary is a small, pea-sized gland located at the base of the brain [Pit05]. It functions as a master
gland, sending signals to the thyroid gland, adrenal glands, ovaries and testes.
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is of great clinical impact due to the high number of facilities treating patients with passive
shaped protons worldwide. But it does not provide a direct answer to which species performs
better on the clinical level because of the disavantage of passive shaping considered in the proton
treatment planning. Therefore, Fig 1.14 shows two treatment plannings for the same patient
comparing the conformity achieved with spot scanned protons (PSI) and IMRT [Lom99]. Cold
spot analysis, for example, indicates that the proton plans generally provide better coverage
of the target. The same applies to healthy tissue and OAR irradiation. The example shown
in the ﬁgure, though, shows better conformity achieved with photons around the brain stem.
It must be noted that the proton treatments did not use inverse planning and that the spot
scanning technique still has some material in the beam path (section 1.2.2), meaning again
that the proton conformity is not at its optimum. A comparison with Fig 1.13, despite being
diﬀerent patients with diﬀerent tumors, reveals a better sparing of the brainstem (an OAR)
with carbon beams.
Figure 1.14: Comparison of dose conformity for spot-scanned protons (left) versus IMRT (right)
for the same patient, from [Lom99]. The proton treatment consists of 2 portals without inverse
planning, whereas the IMRT plan is based on 9 beam portals. A higher dose is delivered to normal
tissue with IMRT but with better conformity achieved at the brainstem (organ at risk).
In conclusion, there is clear evidence that better conformity and target homogeneity is achieved
with heavier ions (e.g. carbon) in comparison to protons. But it seems that there is a lack
of clinical data to prove the beneﬁt of these improvements, i.e. no direct comparison between
heavy ions and protons has yet been performed which includes clinical outcomes. The heavy
ion radiotherapy facility in construction in Heidelberg, planned to deliver ions ranging from
hydrogen to oxygen, can provide an answer to this quest.
Heavier Ions
The possibility of using carbon, neon and silicon beams for radiotherapy was investigated
from 1977 to 1992 at LBNL [Pet94]. Radiobiological studies indicated that the ratio of the
eﬀective dose in the peak to the eﬀective dose in the entrance or plateau region was higher for
carbon than for neon. This ﬁnding suggests that carbon ions are optimal because they deliver
lower doses to normal tissues upstream from the tumor. But the oxygen enhancement ratio1
(OER) was shown to be lower for neon and silicon than for carbon ions, which implies that,
at least theoretically, ions with higher atomic number should be more eﬀective therapeutically
because most tumors are hypoxic. For this reason, argon ions were initially used for patient
1 Ratio of hypoxic to aerated doses needed to achieve the same biological eﬀect, i.e. cell killing (section 1.3).
High OER implies that, in hypoxic conditions, a higher dose must be delivered in order to produce the same
cell killing obtained in oxic conditions [Hal94].
1.3. Radiobiological Rationale for Carbon Ions 17
treatment. After a few treatments, the beam was shifted to silicon and ﬁnally to neon ions in
order to reduced side eﬀects. Energies between 450 and 670 AMeV were selected for the neon
radiotherapy research trials at the Bevatron facility at LBNL, with the most commonly used
being 585AMeV [Pre97].
By the time the Bevatron facility was closed due to budget reasons in 1993, 299 patients had
received at least 10 Gy with neon ions as part of their treatment. In comparison to conventional
photon therapy, improved control and survival rates were achieved for patients with paranasal
sinus tumors, some salivary gland tumors, biliary tract carcinomas, some soft tissue and bone
sarcomas and advanced prostate carcinomas. In some cases the mentioned rates were twice as
high as with photons. But the outcome of treatment of other types of tumors, such as some
brain tumors, melanomas, advanced or recurrent head and neck squamous-cell carcinoma,
non-small-cell lung cancer and esophageal, gastric and pancreatic malignacies was not better
than with conventional therapy. Furthermore, signiﬁcant late eﬀects on normal tissues were
induced [Lyn91b]. It must be stated that most of the selected patients had advanced disease
for which no other form of curative therapy existed.
The tremendous, pioneering work at LBNL allowed to study the response to ion beams of a
variety of tumors and evaluate the corresponding acute and late toxicity. But the use of carbon
ions seems to obviate the complications of heavier ions. They provide better equivalent dose
localization, more sparing of normal tissues and optimal high-LET deposition.
1.3 Radiobiological Rationale for Carbon Ions
Because radiation can cause damage to the normal tissue in front of, and surrounding a deep-
seated tumor, limitations to dose escalation in the tumor arise in order to avoid complications
in the healthy tissue. This poses a more serious problem in radioresistant tumors where higher
doses in the tumor are necessary in order to sterilize all cancer cells [Sch03b].
With carbon ions, in addition to their excellent physical selectivity (section 1.2), the biological
eﬃciency concerning cell killing increases towards the end of the trajectory of the ion [Sch96d].
Therefore, the increase in physical dose at the Bragg peak is further enhanced by an increase
in biological eﬃciency thus increasing the peak-to-plateau ratio of the equivalent dose.
1.3.1 Radiation chemistry, ionization density and DNA damage
Radiation damage along a particle track is caused by direct and indirect mechanisms. Both
are induced by the particle itself and, to a much greater extent, by the electrons ejected as the
particle passes by1. In direct mechanisms the DNA molecules are ionized, therefore damaged,
by these ionizing particles. In indirect mechanisms the damage to the DNA is induced by
free radicals2, produced by the ionizing particles, which diﬀuse and react with the DNA. In
indirect action the energy transferred by the ionizing particle produces free radicals R· such
as e−aq, ·OH, and H· (cells contain more than 70% water). Of these, ·OH is believed to be the
most eﬀective in causing damage because it is an oxydizing agent and can extract an hydrogen
atom from DNA [Hal94]. But the damage induced by indirect action is only stable in the
presence of oxygen in the cellular medium. This experimental fact is not clearly understood.
A possible explanation assumes that the cellular oxygen forms a stable organic peroxide with
the free radical RO2· that attaches to the DNA lesion, preventing the damaged DNA to repair
1 In the case of indirectly ionizing radiation (photons, neutrons) only the ejected electrons contribute to the
ionization of the medium.
2 Highly reactive, neutral, chemical species containing one unpaired electron in the outer shell.
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itself. As a consequence, cells deprived from oxygen (hypoxic) suﬀer less permanent damage
from indirect action than those in an oxygenated medium. Since ∼ 2/3 of the damage induced
by sparsely ionizing radiation (photons, protons) follows this mechanism, it is clear that high-
LET particles (LET > 30 keV/µm), which mostly induce damage via direct action, oﬀer a clear
advantage to treat hypoxic tumors1.
The reason why high-LET particles induce damage mostly by direct action at the end of their
track is that their ionization density is much higher there (Fig. 1.15). At the begining of their
trajectory even high-LET projectiles ionize the medium sparsely due to their high velocities.
The DNA double-helix (∼ 2 nm diameter) might suﬀer single, even double strand breaks that
it can repair. But at the end of its track a high, compact ionization density is deposited by
carbon ions that induces clusters of DNA lesions in both helix strands that the cell cannot
repair. Since the damage is done by direct action upon the DNA the presence or absence of
cellular oxygen is irrelevant. Therefore, the DNA has permanently lost its information and
mitosis (cell division) is no longer possible, i.e. the tumor cannot proliferate and local control
is achieved.
Figure 1.15: Track structure comparison (Monte-Carlo) between protons and carbon ions, af-
ter [Krä94]. The projectile moves along the Z-axis ejecting target atomic electrons. At high
energies both projectiles behave similarly. Only at the carbon Bragg peak a high, compact ion-
ization density can be seen around the track.
1.3.2 Relative biological eﬀectiveness
Because the same physical dose delivered with sparsely ionizing or with high-LET radiation
results in diﬀerent cell damage (section 1.3.1), radiobiology uses the relative biological eﬀec-
tiveness RBE to normalize any physical dose with that delivered with X-rays that would result
in the same cell killing (isoeﬀect):
RBEpart =
Dphotons
Dpart

isoeffect
. (1.10)
1 Normally large tumors with central cores that lack oxygen because the blood supply has been reduced by
the proliferating tumor cells.
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For carbon, RBE values between three and ﬁve are veriﬁed at the Bragg peak for most radiore-
sistant tumors. Fig. 1.16 shows how the match between the RBE maximum and the Bragg
peak enhance the peak-to-plateau ratio of the eﬀective dose.
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Figure 1.16: Correlation between dose, cell survival and RBE, after [Wey03]. The carbon ion
physical dose (top, sum of several Bragg peaks) is multiplied with the RBE (bottom) yielding
a ﬂat biologically eﬀective dose at the tumor (top, eﬀective dose). Measured survival rates of
chinese hamster ovary (CHO) cells are overlayed onto the curve predicted with the local eﬀect
model [Sch96d].
For protons, RBE is normally taken to be 1.1 along most of their track, so no enhancement
of the physical dose takes place. In the last micrometers of their track a rise in the proton
RBE is veriﬁed but with no clinical usefulness. For ions like neon and heavier, their extremely
high LET at the Bragg peak (Fig. 1.4) produces an overkill of cells there yielding no biological
enhancement. In this case the maximum of the RBE occurs even before the Bragg peak, which
has therapeutical disavantages.
It must be stated that the RBE depends on tissue and tumor type, particle species, beam
intensity, beam energy (thus LET) and physical dose [Kra99]. For this reason, more than
100 000 cell cultures (viruses, bacteria and mammalian cells) were irradiated at GSI before
the ﬁrst patient irradiation in order to ﬁne-tune the LEM [Sch96d] used in the treatment
planning [Krä00]. Furthermore, the ejection of atomic electrons by the passage of fast ions was
also measured [Rei98] in order to provide a precise input for track structure calculations [Krä94].
1.4 In-beam PET for In-Situ Monitoring the Beam Localization
The properties of carbon ion beams make it a sharp knife that has to be used with extreme
precaution so that tissue exposure to a high dose within the high-RBE Bragg peak is restricted
to the tumor volume only. For this reason, imaging techniques allowing to monitor the beam
localization as it penetrates the target are highly desired. To date, two methods ﬁrst pro-
posed at LBNL [Tob77, Lla88] are possible, both making use of positron emission tomography
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(PET). The most straightforward one uses β+-decaying radioactive projectiles. This approach
has been followed at the passive-shaping, carbon radiotherapy facility HIMAC, where a ﬁrst
irradiation with 11C or 10C ions is delivered to the patient in order to perform accurate range
measurements [Ura01]. Because the production rate of the secondary beam from the stable
12C ion has an eﬃciency of 1% to 0.1%, respectively, with very expensive consequences aris-
ing from shielding and radiation protection, the following irradiation fractions are performed
with 12C. With this method, the patient is scanned in a commercial PET system following the
radioactive beam irradiation. Activity densities of 103 - 105 BqGy−1 are achieved within the
irradiated volume, depending on the half-life of the isotope. The method oﬀers the advantage
of providing a high activity suitable for high-statistics, artifact-free (from the point of view of
the positron tomograph) PET imaging. It delivers important clinical information by verify-
ing the correspondence between the planned and delivered treatments. But it has two main
drawbacks: (1) the activity created in the tumor and surrounding healthy tissue is washed
out by the blood circulation during the patient irradiation, transport to the PET room and
during the PET scan itself, leading to image blurring and false diﬀerent intensities in highly
versus poorly perfused tissue and, more importantly, (2) anatomical changes occurring during
the course of any a-posteriori fractionated irradiation (section 1.4.2) will no longer be detected,
together with the impossibility of verifying the portal positioning during those irradiation.
The second imaging method allowing to monitor the beam localization makes use of nuclear
fragmentation (section 1.2.1) between stable beam projectiles and target nuclei. This is the
method implemented at GSI [Eng05a], with a specially adapted positron scanner measuring
the activity created during patient irradiation [Eng04b], and therefore named in-beam PET.
1.4.1 Auto-activation and target activation
As the beam penetrates the target, both projectile and target fragments may become radioac-
tive (auto and target activation, respectively) and de-excite by β+ decay. After deposition
of the auto-activated particles and because of the similar range with the original projectile
(section 1.2.1) a peak of activity close to the Bragg peak of the original projectile is formed.
Target projectiles remain in the site of collision and their activation produces a radioactive
trace along the beam path [Tob71, Eng92]. The results from both processes occurring in a
phantom of plexiglas1 can be seen in Fig. 1.17 for carbon ions. The dominant auto-activation
mechanism is the loss of one neutron by the projectile, leading to an activity peak at the site
of deposition of the 11C created in ﬂight (≤ 8% before the Bragg peak of 12C, depending on
the site of creation of the 11C). This allows to control the location of the distal edge of the
beam. The similarity between the sum of all β+-decaying components and the dose deposited
by the stopping beam should be noticed.
The activated fragments in the depth-proﬁle in Fig. 1.17 (top, left axis) will decay with dif-
ferent lifetimes and the corresponding annihilation photons will be emitted in all directions.
Consequently, the deposited activity could be fully registered only if (1) a detector with a solid
angle of 4pi and 100% eﬃciency for 511 keV photons could be installed around the target, which
is not feasible, and (2) the imaging time Timag would satisfy both Timag ≥ 3 · τ(11C) = 88 min2
(unfeasible in radiotherapeutic applications) and Timag ¿ T1/2(washout) ∼ 4min [Tom03],
which is impossible. The term washout denotes the transport of part of the deposited activity
onto other regions of the body by the blood circulation. The limitations imposed by (1) and
(2) are further discussed and optimized in chapters 2 and 6, respectively.
1 Lucite, polymethylmethacralate (PMMA), C5O2H8, with ρ = 1.18 g cm−3.
2 The isotope produced with the longest half-life is 11C. The symbol τ(11C) denotes its lifetime and 3 · τ(11C)
corresponds to its decay by 95%.
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Figure 1.17: Depth-dose distribution of 12C (top, right axis) correlated with auto (middle) and
target activation (bottom) in plexiglas. The PosGen Monte-Carlo code [Has96, Pön04] was used to
simulate the stopping of 5million incoming projectiles with 200.28 AMeV and forming a pencil-like
beam with a cross section of 1 cm FWHM.
Auto-activation occurs also with projectiles heavier than carbon, as summarized in Table 1.3
for ions with potential use in radiotherapy (except neon).
Table 1.3: Positron emitters induced by several stable projectiles and relevant for in-beam PET.
The maximum fragment to projectile range ratio is denoted Rfr/Rpr.
Beam Emitter Rfr/Rpr (%) Eβ+ endpt. (MeV) T1/2
14N7+ 13N7+ 92 1.2 10 min
11C6+ 107 1.0 20.3 min
16O8+ 15O8+ 94 1.7 2.05 min
13N7+ 106 1.2 10 min
20Ne10+ 19Ne10+ 95 2.2 17 s
17F9+ 105 1.7 64 s
Target activation with protons, photons and neutrons
Auto-activation does not take place in suﬃcient quantity (or does not take place at all) for ions
with atomic number lower than carbon, nor with photon or neutron radiotherapy. But several
attempts have been made in order to retrieve imaging information from target activation in
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this regime, with studies ongoing in the case of protons [Par05a] and photons [Bra03, Eng05b].
Protons: Dose monitoring of proton depth-dose proﬁles poses a problem due to the poor
spatial correlation between the dose and the activity proﬁles, which do not show an unitary
relation [Oel96]. Furthermore, at the end of their trajectory the beam energy lies below the
nuclear cross section threshold of ∼10 - 20 MeV, yielding a distal edge positioned before that
of the dose-proﬁle. Nevertheless, lateral deposition can be well localized and range deviations
of pristine Bragg-peaks have been resolved within 1 mm [Par05a], mostly due to the three
times higher activity induced when compared with 12C irradiation with the same dose and
range [Par02b].
Photons: High-energy photons above ∼ 20 MeV interact with tissue nuclei through photonu-
clear reactions producing 11C, 13N and 15O [Hug79]. The reactions rate is proportional to the
photon ﬂuence and thus approximatelly also to the absorbed dose [Jan02, Eng05b].
Neutrons: PET can be used to control the patient beam positioning during fast neutron
therapy when the scan is performed right after the therapy session [Vyn89] and high neutron
energies are used (at least p(40)+Be, i.e. 40 MeV protons impinging on a berilium target) due
to the ∼ 20 MeV threshold for producing 11C and 15O.
1.4.2 In-beam PET in clinical routine at GSI
Considering the short half lives of both auto and target activated fragments, the rather low
activity density created at the fractionated carbon irradiation at GSI (∼200 Bq Gy−1 cm−3,
with typical ﬁelds having Dphys ∼ 0.5 Gy) and the rapid washout of a large part of the pro-
duced activity with T1/2(washout) ∼ 4 min [Tom03], an in-beam PET scanner was the solution
of choice [Eng04b]. But previous in-beam PET research in Berkeley did not result in clinical
routine due to the activation of the BGO-based1 detectors. This arised most probably from
passive beam shaping contaminations [Lla88]. For this reason, special care was taken by the
FZR team before the installation of the dual-head tomograph at the GSI pilot project [Paw96].
Due to the rasterscan technique (section 1.2.2), pencil-like beams are delivered to the target
at GSI resulting in much less, but not negligible, particle spread downbeam from the tar-
get [Sch96b, Gun04a, Gun04b]. After proper data-taking handling, described below, successful
in-beam imaging with BGO-based detectors was achieved.
The positron tomograph BASTEI
The positron tomograph BASTEI (Beta Activity Measurements at the Therapy with Energetic
Ions) installed at the GSI tumor therapy unit consists of two detectors heads with 42× 21 cm2
front area each. Each head was built with detector blocks of BGO coupled to photomultiplier
tubes (PMT) from the ECATr EXACTTM tomograph from CTI PET Systems Inc. A dual-head
tomograph was chosen (Fig. 1.18) in order to avoid interference with the horizontal beam line
and with patient positioning. A total of 8× 4 scintillation block detectors were implemented in
each head, with each detector block consisting of 8× 8 BGO crystals with 54× 54mm2 front
surface each (center-to-center) and 2 cm depth, read with an Anger scheme2 by four PMT.
The data acquisition had to be slighty modiﬁed in order to account for the macrostructure of the
beam delivery (Fig. 1.19). Because of the high random rate registered during beam extractions,
only events registered during the pauses between beam extractions, i.e. beam injection and
acceleration, are taken into account by the reconstruction algorithm (chapter 6). To do this, a
1 Bismuth Germanate, Bi4Ge3O12.
2 The scintillation light is distributed to more than one PMT, with the fraction of light collected by each PMT
yielding the hit crystal [Ang58].
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Figure 1.18: The PET scanner installed at GSI without (left) and with (right) the protection
housing. The patient couch rotates about the isocenter and the two PET heads are positioned
above and below it.
bit, containing the accelerator status information (extraction = 1, no extraction = 0), had to
be introduced into the in-beam PET data words [Eng04b].
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Figure 1.19: Correlation between the beam delivery and the number of detected coincidences
during an in-beam PET scan. The rectangular graph denotes the extraction signal: low during
beam acceleration (no particle delivered, data reconstructed), high during the beam macropulses
(data discarded for reconstruction).
Clinical routine with BASTEI
All fractionated irradiation with carbon ions have been recorded on-line by means of the in-
beam tomograph described above, allowing a comparison to be made between the expected
versus the observed β+ distribution after each irradiation [Eng00]. The PET data, acquired
and saved in list mode format, are submitted to a dedicated, attenuation-correcting, maximum
likelihood expectation maximization algorithm MLEM [Lau99] with a correction for single-
Compton events occurring in the object [Pön03b] which allows to reconstruct the measured
β+ activity in the patient. Visualization is done by merging the in-beam PET images with the
patient CT by using stereotactic coordinates [Pön03b]. The deposited activity distributions do
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Figure 1.20: Dose distribution (top) versus β+ distributions expected (middle) and measured
(bottom) after tumor irradiation. Isodose lines are plotted from 5% (dark-blue contour line) to
95% (magenta) of the maximum dose in intervals of 10%. The activity distributions were obtained
after 50 iterations with the MLEM described in [Lau99, Pön03b]. Note the sparing of the brain
stem in all images, positioned after the distal edge of the beam.
not match exactly the dose applied to the patient due to [Paw97, Eng04b]:
- the diﬀerent nature of both processes: dose deposition arises mainly from interactions with
target atomic electrons whereas the activity distributions are generated by nuclear fragmenta-
tion reactions (section 1.4.1); and
- the washout eﬀect: activity deposited in highly perfused tissue vanishes before that deposited
in less blood perfused regions like bone or large, hypoxic tumors [Kau02, Tom03].
In addition, the reconstructed images of the deposited activity distributions are further dis-
torted because
- a dual head PET scanner provides a space-dependent detector eﬃciency which results in a
position dependent image intensity. This is not possible to correct due to the non-uniform
spatial resolution degradation induced by the gap between the two PET heads (chapter 2);
and
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Figure 1.21: Detection of anatomical modiﬁcations with in-beam PET during the course of
fractionated radiotherapy. The expected β+ distribution for the ﬁrst ﬁeld, ﬁrst fraction (top left),
is compared with the corresponding measured activity (top right). A good correlation is observed
betwen simulated and measured contours at the beam distal edge (high gradients lead to sharp
images). The measured activity during the 16th fraction (bottom right) shows a small activity
focus on the left side of the cavity (right on the image). This was interpreted, and conﬁrmed with a
CT scan, as an over-range of the carbon ions due to a shrinking of the tumor in the right paranasal
sinus. No clinical impact was induced as no organs at risk were exposed (text has details).
- the low cross-section for β+ activity production, the short acquisition times, the small solid
angle coverage of the positron camera and the event loss rate due to the accelerator duty
cycle of ∼ 2/5 (duration of beam extraction over spill repetition time, Fig. 1.19) result in very
low statistics data sets which render the images very noisy (chapter 6).
In order to overcome the mismatch between predicted dose images and the measured β+ ac-
tivity images (Fig. 1.20), a Monte Carlo code [Has96, Pön04] which takes into account the
treatment plan and the course of the irradiation is used which allows to compare, for each
delivered ﬁeld, the expected and the measured β+ distribution in the patient. The careful
analysis of the resulting images allows important information to be retrieved concerning the
quality of the performed irradiation. The clinical experience gained from in-beam PET mon-
itoring [Eng00] the carbon ion radiotherapy treatments within this pilot project proved the
capability of PET to detect, and trigger the immediate correction if needed, unpredictable and
undesirable deviations in the distribution of the delivered dose with respect to the planned
one [Eng04b]. Because deviations in the particle ranges may occur due to (1) physical limita-
tions of the beam model in treatment planning, (2) very small shifts of the delivered portal and
(3) local, anatomical modiﬁcations of density in the target volume relative to the planning CT
(e.g. tumor volume reduction or ﬁlling of cavities with mucus over the fractionated irradiation)
the team of medical physicists chooses entry portals where these seldom occurring deviations
induce no clinical impact by simulating them beforehand [Jäk01]. Nevertheless, mean devia-
tions of 6% of the prescribed dose can occur1 in radiation sensitive OAR such as the spinal
1 Mean deviation calculated assuming the errors occur systematically the same way during all fractions, which
is highly improbable. This deviation becomes more important if the number of treatment fractions is reduced.
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chord [Kar03], which reveals the importance of in-beam PET monitoring. In summary, de-
spite occurring very seldomly and, as mentioned, with no clinical implications to date, these
deviations can be detected on the basis of in-beam PET images and local deviations from the
planned dose can be quantiﬁed [Par02a, Eng04a].
An example is shown in Fig. 1.21, which presents one case in which this analysis identifyed
patient morphologic changes during the course of the treatment sessions. Consequences to the
delivered dose could be locally quantiﬁed [Par02a, Par04]. The left images show the expected
β+ distributions for the ﬁrst ﬁeld, ﬁrst fraction (top) and for the 16th fraction (bottom). The
beam enters the patient from the right (left in the image) and stops at the edge of the paranasal
sinus. The right images show the corresponding measured distributions. A remarkable match
can be seen between simulated and measured contours at the beam distal edge (high gradients
lead to sharp images) in the ﬁrst fraction. During the 16th fraction a small activity focus could
be seen on the left side of the cavity (right on the image), which was ﬁrst interpreted, and later
conﬁrmed with a CT scan, as an over-range of the carbon ions due to a shrinking of the tumor
present in the right paranasal sinus. In this case the over-range was not of clinical signiﬁcance
since the organic structures exposed to it did not include an OAR, together with the fact that
the displayed images correspond to a slice 20.16mm below the isocenter, where the maximum
dose was delivered and, thus, present contours of smaller doses. Although this example shows
deviations with no clinical signiﬁcance, it proves well the ability of in-beam PET to monitor
the quality of carbon ion tumor irradiation.
1.5 Summary
At GSI Darmstadt a heavy ion therapy unit that exploits the radiotherapeutic advantages of
carbon ion beams has treated over 250 patients to date with very promising clinical results.
The main advantages of heavy charged particles in respect to photons in radiotherapy are
twofold: (1) the inverse depth-dose proﬁle allowing higher doses at the tumor while sparing
proximal healthy tissue and (2) the possibility to drive a charged beam by magnetic deﬂection,
avoiding all material in the beam path and providing optimum tumor conformity.
The main advantages of carbon ions in respect to the spectrum of charged particles in radio-
therapy are threefold: (1) the lateral and range straggling decrease with the square root of
the atomic number of the projectile, allowing best beam conformity while the tail after the
Bragg peak, due to fragmentation projectiles, is still quite small; (2) the relative biological
eﬀectiveness of carbon ions increases at their Bragg peak, which enhances the biological dose
at the tumor, thus allowing a control of otherwise radioresistant tumors and (3) in-beam PET
oﬀers a non-invasive, in-situ, non-dose-proportional monitoring of the beam localization during
therapeutic irradiation .
After the physics processes inherent to positron activity production were described, the techno-
logical solutions implemented for the ﬁrst time by the team from FZ Rossendorf were presented,
followed by two head and neck treatment examples that underline the clinical importance of
in-beam PET in monitoring tumor irradiation with carbon ions. The following chapters try
to further optimize several technological aspects of in-beam PET introduced in this chapter,
presenting in addition studies leading to the implementation of in-beam PET onto isocentric,
rotating ion beam deliveries (gantries) as well as ﬁxed, horizontal beam lines.
